Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 3/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29817538 | 1.00 | ALDH1A1 (0.31) | ALDH1A1KDM4EHPGDHSD17B10L3MBTL1 | |
| SCHEMBL7084293 | 0.89 | ALDH1A1 (0.34) | ALDH1A1KDM4EHPGDHSD17B10L3MBTL1 | |
| SCHEMBL29601329 | 0.89 | ALDH1A1 (0.34) | ALDH1A1KDM4EHPGDHSD17B10L3MBTL1 | |
| SCHEMBL5698005 | 0.89 | ALDH1A1 (0.34) | ALDH1A1KDM4EHPGDHSD17B10L3MBTL1 | |
| SCHEMBL30384808 | 0.84 | MEN1 (0.34) | ALDH1A1TSHR | |
| SCHEMBL14874589 | 0.84 | MEN1 (0.34) | ALDH1A1TSHR | |
| SCHEMBL6424052 | 0.84 | THRB (0.38) | ALDH1A1ACACB | |
| SCHEMBL330418 | 0.83 | HSD17B10 (0.35) | ALDH1A1KDM4EHPGDHSD17B10L3MBTL1 | |
| SCHEMBL29489300 | 0.83 | HSD17B10 (0.35) | ALDH1A1KDM4EHPGDHSD17B10L3MBTL1 | |
| SCHEMBL2457034 | 0.80 | L3MBTL1 (0.36) | ALDH1A1KDM4EHPGDHSD17B10L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132972-A1 | PROCESS FOR PREPARING A DENTAL RESIN-MODIFIED GLASS IONOMER COMPOSITION | DENTSPLY SIRONA INC. (US) | 2023-05-04 | — | — | US | disclosed |
| EP-3559054-B1 | PROCESS FOR PREPARING A DENTAL RESIN-MODIFIED GLASS IONOMER COMPOSITION | DENTSPLY DETREY GMBH (DE) | 2020-10-14 | — | — | EP | disclosed |
| EP-3559054-A1 | PROCESS FOR PREPARING A DENTAL RESIN-MODIFIED GLASS IONOMER COMPOSITION | Dentsply DeTrey GmbH (DE) | 2019-10-30 | — | — | EP | disclosed |
| WO-2018114415-A1 | PROCESS FOR PREPARING A DENTAL RESIN-MODIFIED GLASS IONOMER COMPOSITION | DENTSPLY DETREY GMBH (DE) | 2018-06-28 | — | — | WO | disclosed |
| EP-3339335-A1 | PROCESS FOR PREPARING A DENTAL RESIN-MODIFIED GLASS IONOMER COMPOSITION | Dentsply DeTrey GmbH (DE) | 2018-06-27 | — | — | EP | disclosed |
| EP-2415794-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | Showa Denko K.K. (JP) | 2012-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230132972-A1 | PROCESS FOR PREPARING A DENTAL RESIN-MODIFIED GLASS IONOMER COMPOSITION | PICALM, COG1, GYPA | ALDH1A1 1756/4885KDM4E 1531/4885HPGD 2035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.